Skip to main content
. 2022 Apr 20;9:837719. doi: 10.3389/fnut.2022.837719

Table 3.

Baseline patient's data from all included studies in this meta-analysis.

Study Initial BMI (kg/m2) Handgrip strength (kg/f) Muscle cross-section area (cm2) Muscle Density (HU) SMI (cm2/m2)
Tuzun et al. (28) NR Non-severe: 30.59 ± 13.39
Severe: 27.38 ± 14.04
NR NR NR
Kara et al. (26) Mild: 26.8 ± 5.3 Moderate: 29.3 ± 5.4 Severe: 30.5 ± 6.6 Mild: 35.1 ± 11.2
Moderate: 34.7 ± 11.1
Severe: 26.5 ± 12.4
NR NR NR
Rossi et al. (27) All: 29.30 ± 4.58
Survivors: 28.25 ± 4.43
Deaths: 30.58 ± 5.29
NR All: 16.66 ± 9.37
Survivors: 16.46 ± 9.40
Deaths: 17.59 ± 9.34
All: 37.79 ± 8.55
Survivors: 38.38 ± 8.58
Deaths: 35.05 ± 8.03
NR
Viddeleer et al. (20) All: 28.9 ± 6.1
Alive: 28.8 ± 6.2
Dead: 29.0 ± 5.8
NR All: NR
Alive: 108.0 (86.5–124.4)a
Dead: 104.0 (83.3–116.7)a
All: NR
Alive: 27.6 ± 10.9
Dead: 24.0 ± 10.1
All: NR
Alive: 36.1 ± 9.1
Dead: 35.7 ± 9.5
Gil et al. (18) All: 29.5 ± 6.9 All: 21 (15–30)a
Survivors: 22 (15–30)a
Deaths: *
All: 12 (12–19)a# Survivors: 16 (12–18)a# Deaths* NR NR
Yi et al. (30) NR NR NR NR All: 24.2 (15.3–40.2)b Severe:25.4 (20.5–40.2)b Non-severe: 23.7 (15.3–37.3)b
Yang et al. (29) All: 23.4 (21.9–25.3)a Critical: 24.8 (22.5–26.1)a Non-critical: 23 (21.4–24.8)a NR All: 96.2 (79.0–118.2)a Critical: 93.3 (77–118.4)a Non-critical: 98.5 (81.7–117.2)a All: 32.3 (23.7–39.3)a
Critical: 25.4 (16.3–30.6)a
Non-critical: 35.7 (28.1–41.3)a
NR

Values are mean ± SD unless otherwise specified.

a

Median (IQR).

b

Median (min–max).

*

Unpublished data.

#

Value are in cm1.

NR, Not reported; SMI, Skeletal muscle index; HU, Hounsfield units.